Clonidine and Stem cell transplant - a phase IV clinical study of FDA data

Summary:

Stem cell transplant is reported as a side effect among people who take Clonidine (clonidine), especially for people who are male, 40-49 old, also take Lisinopril, and have Multiple myeloma.

The phase IV clinical study analyzes which people have Stem cell transplant when taking Clonidine. It is created by eHealthMe based on reports of 63,883 people who have side effects when taking Clonidine from the FDA, and is updated regularly.

What is Clonidine?

Clonidine has active ingredients of clonidine. It is often used in high blood pressure. eHealthMe is studying from 65,644 Clonidine users. Check the latest studies of Clonidine.

What is Stem cell transplant?

Stem cell transplant is found to be associated with 431 drugs and 383 conditions by eHealthMe. Check the latest studies of Stem cell transplant.

On Jul, 11, 2026

63,883 people reported to have side effects when taking Clonidine.
Among them, 13 people (0.02%) have Stem cell transplant.

Could Clonidine cause Stem cell transplant?

Among these 13 people:

What is the gender of people who have Stem cell transplant when taking Clonidine? *

female: 30.77 %
male: 69.23 %

What is the age of people who have Stem cell transplant when taking Clonidine? *

What are other drugs people take besides Clonidine? *

What are other side effects people have besides Stem cell transplant? *

Anaemia (lack of blood): 6 people, 46.15%
Deep Venous Thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis): 6 people, 46.15%
Swallowing Difficulty: 6 people, 46.15%
Pain: 5 people, 38.46%
Weakness: 5 people, 38.46%
Dyspnea (difficult or laboured breathing): 5 people, 38.46%
Swelling: 5 people, 38.46%
Spinal Osteoarthritis (joint cartilage loss in spine): 5 people, 38.46%
Musculoskeletal Stiffness (stiffness of the body's muscles, joints, tendons, ligaments and nerves): 5 people, 38.46%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 4 people, 30.77%

What are the existing conditions these people have? *

Multiple Myeloma (cancer of the plasma cells): 4 people, 30.77%
Depression: 3 people, 23.08%
Rashes (redness): 1 person, 7.69%
Primary Myelofibrosis (primary disorder of the bone marrow): 1 person, 7.69%
Neuropathy Peripheral (surface nerve damage): 1 person, 7.69%
Nausea And Vomiting: 1 person, 7.69%
Nausea (feeling of having an urge to vomit): 1 person, 7.69%
Itching: 1 person, 7.69%
B Precursor Type Acute Leukaemia (lymphoid cancer): 1 person, 7.69%
Acute Lymphocytic Leukemia (All) (cancer of the white blood cells characterized by excess lymphoblasts): 1 person, 7.69%

* Approximation only. Some reports may have incomplete information.

Do you take Clonidine and have Stem cell transplant?

- Check whether Stem cell transplant is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Clonidine:

Clonidine (65,644 reports)

Browse all side effects of Clonidine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Stem cell transplant:

Stem cell transplant (431 drugs)

Browse all the conditions that are associated with Stem cell transplant:

Stem cell transplant (383 conditions)

Related publications that referenced our studies

Teimoory M, Arefi M, Behnoush B, Bastani B, "Promethazine and Treatment Refractory Agitation in Clonidine Toxicity", International Journal of Medical Toxicology and Forensic Medicine, 2013 Mar .
Teimoory M, Arefi M, Behnoush B, Bastani B, "Promethazine and Treatment Refractory Agitation in Clonidine Toxicity", International Journal of Medical Toxicology and Forensic Medicine, 2013 Mar .

How the study uses the data?

The study uses data from the FDA. It is based on clonidine (the active ingredients of Clonidine) and Clonidine (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.